NASDAQ:ODTX Odyssey Therapeutics Q1 2026 Earnings Results & Report $19.36 +0.22 (+1.15%) As of 04:00 PM Eastern Odyssey Therapeutics missed analyst earnings expectations in its Q1 2026 results, released June 17, 2026. The company reported EPS of -$6.77 versus the -$1.31 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2026Report DateJune 17, 2026TimeAfter Market ClosesConference Call8:00 AM ET Odyssey Therapeutics EPS ResultsActual EPS-$6.77Consensus EPS -$1.31Beat/MissMissed by -$5.46One Year Ago EPSN/AOdyssey Therapeutics Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Odyssey Therapeutics Q1 2026 Earnings FAQ Did Odyssey Therapeutics beat earnings estimates for Q1 2026? Odyssey Therapeutics (NASDAQ:ODTX) reported earnings of -$6.77 per share for Q1 2026, missing the consensus estimate of -$1.31. The report was announced on Wednesday, June 17, 2026. Odyssey Therapeutics Earnings HeadlinesWhat is HC Wainwright's Estimate for ODTX FY2026 Earnings?November 12, 2026 | americanbankingnews.comOdyssey Therapeutics Announces Publication Highlighting Differentiated Therapeutic Potential of TNFR2 AgonismNovember 10, 2026 | markets.businessinsider.comEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.November 16 at 1:00 AM | Behind the Markets (Ad)What is HC Wainwright's Forecast for ODTX Q1 Earnings?November 9, 2026 | americanbankingnews.comOdyssey Therapeutics Advances Early OD-001 Study as Investors Watch for Drug Development SignalsNovember 5, 2026 | tipranks.comOdyssey Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 4, 2026 | marketscreener.comMSee More Odyssey Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Odyssey Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Odyssey Therapeutics and other key companies, straight to your email. Email Address About Odyssey TherapeuticsOdyssey Therapeutics (NASDAQ:ODTX) is a biotechnology company focused on discovering and developing medicines for inflammatory and autoimmune diseases. Its research centers on the immune system and biological pathways that may be targeted to address these conditions. Founded in 2021, the company uses drug-discovery capabilities to identify and advance potential therapies. Its business is research and development rather than the sale of marketed medicines. Odyssey is based in the United States. As a research-focused biotechnology company, its activities are centered on developing potential treatments rather than serving patients through a broad commercial product operation.View Odyssey Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?3 Building-Materials Stocks Rallying While Homebuilders Struggle to Find BuyersMarketBeat Week in Review – 11/9 - 11/133 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?Nu Holdings Earnings Show a Compounder Priced Like a Brazil BetCould Big Buybacks Be the Next Catalyst for These 3 AI Stocks?Cerebras Q3 Results: How Much More Proof Does Wall Street Need? Upcoming Earnings Walt Disney (11/17/2026)Home Depot (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.